State pharmaceutical approval letter alleged false case of road shows on the eve of "troubl
Beijing, Shanghai and Shenzhen are the three road shows, April 6 issue of the letter should state listing Pharmacy Trouble.
Letter state pharmaceutical chairman and general manager Zhang Guanfu March 30 when communicating with institutional investors, said the company received a letter from the Commission, it was reported drug use fake approval letter states, illegal production called "Tonic Capsule" products.
Letter state pharmacy is located in Guiyang, is a production of the treatment of cardiovascular and digestive herbs, Chinese patent medicine Yaoqi. Tonic Capsule is one of the company's main products. Tonic Capsule 2009 Sell Income of 29,972,500 yuan, accounting for 8.93% current sales revenue, gross profit 17,712,000 yuan, accounting for 7.59% current total company gross margin.
However, the December 19, 2008, the State Food and Drug Administration had issued the letter of state pharmaceutical notice requirements of its own December 31, 2008 shall not be reproduced from these products, "but has produced Drugs Can continue to sell. "
Letter states pharmacy has disclosed in its prospectus information about the above discontinued. Prospectus that the end of 2009 the basic sales of the product is completed, there are 498,800 yuan stock, the product will be discontinued after the year 2010 and the performance impact. But Zhang Guanfu on March 30 said the inventory will be completed in 2010 digest, completely withdraw from the market in 2011.
For the new situation, as a major business risk, Zhang Guanfu have to be explained to institutional investors. Dispute
approval Tonic Capsule on the shutdown, Zhang Guanfu screaming helpless. In 2002, the letter states Pharmaceuticals acquired a local pharmaceutical companies in Guizhou, the pharmaceutical companies have produced Tonic Capsule for approval. Zhang Guanfu said the merger prior to the SFDA issued a formal letter to confirm approval of the pharmaceutical companies that control the authenticity, the State Food and Drug Administration issued a formal letter, said the confirmation.
Merger, the letter states corresponding received the drugs the pharmaceutical production qualification, and in 2002 to organize the production during 2008.
However, according to "Gansuribao" reports, "Tonic" series products are Academy of Engineering, Sun Yan during the decentralized Dingxi the results of painstaking research, including granules, capsules and tablets in three dosage forms. In 1984, Sun Yan left his inventions former Gansu righting medicine?? Set West righting pharmaceutical. Later, Yan Sun and set the West and the original blue Fuzheng pharmaceutical drug groups combined to transform the particle formulation, developed in 1993 and began production of capsule dosage forms, access to national patent protection in 2003.
"First Financial Daily" reporters in the State Intellectual Property Office website search for "Tonic" ownership of patents, November 28, 2003, Gansu Science and Technology Co., Ltd. for the righting of drug known as "drugs Tonic Preparation of improvement "in the patent.
"Gansuribao" the report said, from the second half of 2001, Guizhou, Sichuan and other places large numbers, "the letter states" brand "Tonic Capsule," the letter states Pharmaceutical Co., Ltd. of Guizhou to "increased size" and "Concentrated Capsule" as an excuse for the state of approval. Interestingly, this time in the letter state pharmaceutical buy "Guizhou local pharmaceutical companies" before.
Since then, the two pharmaceutical companies sent people to Gansu to Beijing several times, and the State Food and Drug Administration and other interested parties, "argued" the State Food and Drug Administration finally on December 19, 2008 the cut-off notice issued .
SFDA's website in search named "Tonic Capsule" attribution of drug approval, Gansu blue drug Pharmaceutical Group Co., Ltd. and Gansu Science and Technology Co., Ltd. has a centralizer of drug approvals are valid for 03 2007 12 to July 22, 2013.
Letter state pharmaceutical chairman and general manager Zhang Guanfu March 30 when communicating with institutional investors, said the company received a letter from the Commission, it was reported drug use fake approval letter states, illegal production called "Tonic Capsule" products.
Letter state pharmacy is located in Guiyang, is a production of the treatment of cardiovascular and digestive herbs, Chinese patent medicine Yaoqi. Tonic Capsule is one of the company's main products. Tonic Capsule 2009 Sell Income of 29,972,500 yuan, accounting for 8.93% current sales revenue, gross profit 17,712,000 yuan, accounting for 7.59% current total company gross margin.
However, the December 19, 2008, the State Food and Drug Administration had issued the letter of state pharmaceutical notice requirements of its own December 31, 2008 shall not be reproduced from these products, "but has produced Drugs Can continue to sell. "
Letter states pharmacy has disclosed in its prospectus information about the above discontinued. Prospectus that the end of 2009 the basic sales of the product is completed, there are 498,800 yuan stock, the product will be discontinued after the year 2010 and the performance impact. But Zhang Guanfu on March 30 said the inventory will be completed in 2010 digest, completely withdraw from the market in 2011.
For the new situation, as a major business risk, Zhang Guanfu have to be explained to institutional investors. Dispute
approval Tonic Capsule on the shutdown, Zhang Guanfu screaming helpless. In 2002, the letter states Pharmaceuticals acquired a local pharmaceutical companies in Guizhou, the pharmaceutical companies have produced Tonic Capsule for approval. Zhang Guanfu said the merger prior to the SFDA issued a formal letter to confirm approval of the pharmaceutical companies that control the authenticity, the State Food and Drug Administration issued a formal letter, said the confirmation.
Merger, the letter states corresponding received the drugs the pharmaceutical production qualification, and in 2002 to organize the production during 2008.
However, according to "Gansuribao" reports, "Tonic" series products are Academy of Engineering, Sun Yan during the decentralized Dingxi the results of painstaking research, including granules, capsules and tablets in three dosage forms. In 1984, Sun Yan left his inventions former Gansu righting medicine?? Set West righting pharmaceutical. Later, Yan Sun and set the West and the original blue Fuzheng pharmaceutical drug groups combined to transform the particle formulation, developed in 1993 and began production of capsule dosage forms, access to national patent protection in 2003.
"First Financial Daily" reporters in the State Intellectual Property Office website search for "Tonic" ownership of patents, November 28, 2003, Gansu Science and Technology Co., Ltd. for the righting of drug known as "drugs Tonic Preparation of improvement "in the patent.
"Gansuribao" the report said, from the second half of 2001, Guizhou, Sichuan and other places large numbers, "the letter states" brand "Tonic Capsule," the letter states Pharmaceutical Co., Ltd. of Guizhou to "increased size" and "Concentrated Capsule" as an excuse for the state of approval. Interestingly, this time in the letter state pharmaceutical buy "Guizhou local pharmaceutical companies" before.
Since then, the two pharmaceutical companies sent people to Gansu to Beijing several times, and the State Food and Drug Administration and other interested parties, "argued" the State Food and Drug Administration finally on December 19, 2008 the cut-off notice issued .
SFDA's website in search named "Tonic Capsule" attribution of drug approval, Gansu blue drug Pharmaceutical Group Co., Ltd. and Gansu Science and Technology Co., Ltd. has a centralizer of drug approvals are valid for 03 2007 12 to July 22, 2013.